Substances · Phenethylamine derivatives
5-MAPB
- Preferred name
- 5-MAPB
- IUPAC name
- 1-(1-benzofuran-5-yl)-N-methylpropan-2-amine
- Parent CAS number (reference)
- 1354631-77-8
- Molecular formula
- C12H15NO
- Molecular weight
- 189.25 g/mol
- InChIKey
- ZOVRTIPCNFERHY-UHFFFAOYSA-N
- PubChem
- CID 102336592
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
5-(2-Methylaminopropyl)benzofuran 5MAPB 5 MAPB
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
5-MAPB
Receptor Telemetry & Mechanism of Action
5-MAPB is the N-methyl analogue of 5-APB and a benzofuran entactogen. It releases serotonin with dopamine and norepinephrine and feels closer to MDMA than 6-APB does: warmer, less psychedelic, and less openly stimulating. The 5-position oxygen is associated with a more stimulating balance than the 6-position, but 5-MAPB is still a serotonin releaser first. PsychonautWiki notes that the hydrochloride is substantially more potent by mass than the succinate, so a milligram of one salt is not a milligram of the other.
Biotransformation & Active Metabolites
Not a prodrug of MDMA. The benzofuran itself is the releaser. Salt form changes the mass that must be weighed. The freebase formula C12H15NO (189.25 g/mol) is the parent amine, not the succinate.
Temporal Pharmacokinetics
Warm, MDMA-like entactogen with less visual and psychedelic overlay than 6-APB and a meaningful next-day flatness.
- Onset 20–60 minutes
- Peak Window 2–4 hours
- Total Window 5–8 hours
- Residual / Half-Life After-effects 6–48 hours of low mood, fatigue, and insomnia. That tail is serotonergic depletion, not a sign to redose.
Threshold 20 mg, light 40–60 mg, common 60–80 mg, strong 80–100 mg, heavy above 100 mg on the PsychonautWiki oral sheet. Come-up is 45–90 minutes. repeated exposure because the first hour felt mild is the usual overshoot, and a succinate-to-hydrochloride swap makes the same number too strong.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
20 mg
A soft mood lift without a roll.
Light body warmth.
40–60 mg
Gentle empathy, music enhancement, and mild stimulation.
Jaw tension, appetite loss, and pupil dilation starting.
60–80 mg
Clear emotional openness, tactile enhancement, and mood elevation with less 'push' than MDMA.
Bruxism, sweating, tachycardia, and a warm body load.
80–100 mg
Intense entactogenic state, some visual drifting, and less additional warmth per extra milligram.
Hyperthermia risk, nausea, strong bruxism, and a heavier cardiovascular load.
100 mg+
Overwhelmed, anxious, or confused rather than more empathic. Stacking a second releaser here is a serotonin emergency.
Severe hyperthermia, hypertension, and seizures with tramadol, MAOIs, or MDMA.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
5-MAPB is already a serotonin releaser. A second releaser is the serotonin-syndrome combination.
Extra serotonergic load and, for tramadol, a lower seizure threshold.
Elevated Hazard — Avoid
Cardiovascular strain and, with NBOMes, seizures and vasospasm.
Mask intoxication and raise hyperthermia and hyponatremia risk, the same pattern as MDMA.
Caution / Receptor Attenuation
Often blunt the roll and still leave the cardiovascular load. They do not make an MAOI or MDMA combination safe.
Hydrochloride weighs less per active molecule than succinate. Using a hydrochloride mass with a succinate habit overshoots.
Structural Isomer & Sibling Comparison
5-MAPB is the shorter, more MDMA-like benzofuran: common 60–80 mg, 5–8 hours, less psychedelic than 6-APB. 6-APB common is 60–90 mg but lasts 7–10 hours, comes up for 1–2 hours, and carries a stronger 5-HT2B cardiotoxicity concern with frequent use. 6-MAPB is the N-methyl-6 analogue; TripSit places its common oral band at 40–80 mg. All three share the 'never stack releasers' rule. 5-MAPB is not 5-MeO-MiPT and not 4-FA.
Physicochemical Stability & Storage
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
Serotonergic tolerance is the limiting factor. The warm phase fades with closely spaced uses while stimulation and side effects remain. Cross-tolerance with MDMA, 4-FA, and the other benzofurans. PsychonautWiki's 6-APB sheet describes a multi-week return to baseline for that sibling; 5-MAPB deserves the same spacing. The crash is low mood and fatigue, not opioid withdrawal. Psychological urge to redose during the 45–90 minute come-up is the acute hazard.
Chemical Architecture & Structural Profile
5-MAPB (1-(1-benzofuran-5-yl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C12H15NO and a molar mass of 189.25 g/mol. The parent molecule is indexed under CAS registry number 1354631-77-8 and in the NCBI PubChem database as CID 102336592 (Standard InChIKey: ZOVRTIPCNFERHY-UHFFFAOYSA-N). This molecule shares its empirical formula (C12H15NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1354631-77-8), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 5-MAPB is indexed within the Substituted amphetamines, Substituted benzofurans structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (AE) — National Regulatory Authority (AE) (2026-11-12)